Ключевые слова:
сўлак бези, сиалоаденит, тизимли касалликлар, Шёгрен синдроми, умумий қон таҳлили, биокимё, коагулограмма, ANA, ANCA, лаборатор диагностика.Библиографические ссылки
1. Aqrawi L.A., Ivanchenko M., Björk A., et al. Diminished CXCR5 expression in peripheral blood of patients with Sjögren’s syndrome may relate to both genotype and salivary gland homing. Clinical & Experimental Immunology. 2018;192(3):259–270. doi:10.1111/cei.13118.
2. Aqrawi L.A., Ivanchenko M., Björk A., et al. Diminished CXCR5 expression in peripheral blood of patients with Sjögren’s syndrome may relate to both genotype and salivary gland homing. Clinical & Experimental Immunology. 2018;192(3):259–270. doi: 10.1111/cei.13118.
3. Bowman S.J. Primary Sjögren’s syndrome. Lupus. 2018;27(1_suppl):32–35.
4. Brito-Zerón P., Baldini C., Bootsma H., et al. Sjögren syndrome. Nature Reviews Disease Primers. 2016; 2:16047. doi:10.1038/nrdp.2016.47.
5. Lee Y.H., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to Sjögren’s syndrome: a meta-analysis. International Journal of Immunogenetics. 2025;52(1):24–32. doi: 10.1111/iji.12702.
6. Mariette X., Criswell L.A. Primary Sjögren’s syndrome. New England Journal of Medicine. 2018; 378(10):931–939. doi:10.1056/NEJMcp1702514.
7. Nocturne G., Mariette X. B cells in the pathogenesis of primary Sjögren syndrome. Nature Reviews Rheumatology. 2018;14(3):133–145. doi:10. 1038/nrrheum.2018.1.
8. Ramos-Casals M., Brito-Zerón P., Bombardieri S., et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Annals of the Rheumatic Diseases. 2020;79(1):3–18.
9. Shiboski C.H., Shiboski S.C., Seror R., et al. 2016 ACR/EULAR classification criteria for primary Sjögren’s syndrome. Annals of the Rheumatic Diseases. 2017;76(1):9–16.
10. Yura Y., Hamada M. Outline of salivary gland pathogenesis of Sjögren’s syndrome and current therapeutic approaches. International Journal of Molecular Sciences. 2023;24(13):11179. doi:10.33 90/ijms241311179.